Recently released World Health Organization (WHO) guidance for best
practices for clinical trials set a new standard for clinical research, placing
participant and community engagement at the forefront to ensure trials meet
public needs and build trust. Key updates focus on inclusive trial
reforms, particularly for underrepresented groups like children, pregnant
women, and older adults.
This guidance advocates for risk-based approaches rather than blanket
regulations, emphasizing ethics, efficiency, and tailored oversight. WHO
further provides practical recommendations for health and regulatory
authorities to streamline and support clinical trials, backed by
recommendations for sustained funding.
SFA Foundation through its Clinical Research and Trials Community Programme
and the World Health Organization (WHO) have planned a
joint webinar for the African clinical research ecosystem players to explore
these transformative guidelines and practical steps to align clinical trials
with WHO standards and strengthen local research capacities.
The Carnegie African Diaspora Fellowship Program (CADFP) is a fellowship program for African institutions in Ghana, Kenya, Nigeria, South Africa, Tanzania, Uganda and member institutions of the African Research Universities Alliance (ARUA) and partner universities with the Consortium for Advanced Research Training in Africa (CARTA) to host an African-born scholar to work on projects in research collaboration, graduate student teaching/mentoring and curriculum co-development. The application process has two parts.
The Carnegie African Diaspora Fellowship Program is a fellowship program that supports educational projects in African higher education institutions. This is an opportunity for African-born scholars living in the U.S. or Canada to travel to Africa to work on a project in one of the following: Innovations in curriculum co-development, new approaches and methods to graduate mentoring and training, and impactful research collaboration and capacity strengthening.
Applications due Monday, Mar. 4, 2024.
Read moreThe Stop
TB Partnership Working Group on New TB Vaccines (WGNV) and the National
Institute for Allergy and Infectious Diseases (NIAID)are
co-hosting a workshop on the topic of Recognition and Control of Mtb
Infected Cells: From Basics to the Clinic. This workshop is intended to address
the need for correlates and to identify platforms that measure recognition or
control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for
Research and Development of New TB Vaccines and the Strategic Framework for
New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030.
The overall goals of this workshop
are to:
The workshop format will be largely
discussion-based. Each session will have three short presentations that will
provide a high-level overview of key topics within the session theme, followed
by a discussion between the session chairs, speakers, and participants.
Click here
to view the programme and
speakers.
This workshop is free of charge and
open to any participants interested in this topic.
The International Society for Infectious Diseases (ISID) and the Swiss
Society for Infectious Diseases (SSI) are inviting applications for their joint
Infectious Diseases Research Fellowship Program. The purpose of this programme
is to support infectious disease physicians and scientists from under-resourced
countries through multidisciplinary clinical and laboratory training at a
select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID
Fellowship programme is open to applicants who are 40 years or younger,
citizens and permanent residents of under-resourced countries or Eastern
Europe. The deadline for applications is 16 June 2023.
More information: https://na.eventscloud.com/eSites/748378/Homepage